Team Members

Tao is NeuCyte’s President and CEO and oversees management, focusing on corporate strategy, business development, finance, and drug discovery.

Angela leads NeuCyte’s Cell Production team, where she works on efficiently producing new batches of iNs and related platforms to discover the newest and most directed therapies for neurological diseases.

Hui leads the Drug Discovery R&D for the Epilepsy and Fragile X Syndrome programs at NeuCyte. His passion for discovering medicines that will help patients truly drives his efforts in creating new approaches and opportunities for CNS drug discovery using human neurons

Dominique Lessard is the Head of Business Development at NeuCyte where she applies her expertise in network growth and development, science communication, and science-driven advocacy to lead outreach efforts and manage strategic partnerships.

Wayne is the Head of Neuroscience at Neucyte where he oversees efforts to develop human iPSC-based neurological disease models and functional and phenotypic assays that can be utilized in drug discovery screening platforms to identify novel therapeutic compounds for CNS diseases.